Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
deals
3
×
life sciences
national blog main
boston top stories
clinical trials
fda
investing
national top stories
roche
san francisco blog main
akouos
astellas pharmaceuticals
avapritinib
biopharma
blueprint medicines
california institute for biomedical research
cstone pharmaceuticals
decibel therapeutics
duchenne
eli lilly
europe blog main
europe top stories
european medicines agency
fisogatinib
flatiron health
frequency therapeutics
genentech
harvard university
hearing loss
hepatocellular carcinoma
jeff albers
jeffrey karp
licensing
m&a
medullary thyroid cancer
multiple sclerosis
muscular dystrophy
What
fda
3
×
approval
drug
medicines
roche
therapeutics
affects
americans
approved
betting
billion
biopharma
blueprint
cancer
candidate
currently
date
deal
developing
duchenne
frequency
gene
hearing
historic
ipo
loss
marketing
medicine
meds
millions
muscle
pact
plans
puts
recently
regenerative
regulatory
ret
review
rna
Language
unset
Current search:
fda
×
boston
×
deals
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds